Literature DB >> 8307475

Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process.

M C Winslet1, A Allan, V Poxon, D Youngs, M R Keighley.   

Abstract

The high incidence of clinical remission after faecal diversion for Crohn's colitis suggests the faecal stream may play a part in the inflammatory mechanism. The effect of faecal diversion (n = 22) and restoration of intestinal continuity (n = 10) was assessed in patients with Crohn's colitis and compared with controls. Faecal diversion produced significant improvement in the disease activity index mean (SEM) (before 176 (9); after 114 (9), p < 0.01) and serum albumin concentrations (before 33 (3.0); after 38 (3.0), p < 0.05) in all patients with Crohn's colitis. The crypt cell production rate (CCPR) was maintained after faecal diversion for Crohn's colitis but fell in the control group (before = 3.6 (0.8)), at two (1.4 (0.4), p < 0.02), and six weeks (1.6 (0.4), p < 0.05). Mucosal glucosamine synthetase activity, reflecting glycoprotein synthesis, was significantly lower in patients with Crohn's colitis (analysis of variance p < 0.05) after diversion but was maintained in the control group. Restoration of intestinal continuity failed to produce reciprocal changes. The sustained cellular proliferation and fall in glycoprotein synthesis in Crohn's colitis after faecal diversion may represent the end of an exaggerated protective response and regenerative hyperplasia after exclusion of the faecal stream. This study suggests the faecal stream may participate in the inflammatory process in Crohn's colitis. The underlying mechanism is unknown.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8307475      PMCID: PMC1374500          DOI: 10.1136/gut.35.2.236

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  48 in total

1.  Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.

Authors:  C Andre; L Descos; P Landais; J Fermanian
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

2.  Crypt cell production rate in ulcerative proctocolitis: differential increments in remission and relapse.

Authors:  A Allan; J B Bristol; R C Williamson
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

3.  Epithelial cell kinetics in the descending colon of the rat. II. The effect of experimental bypass.

Authors:  R P Rijke; R Gart; N J Langendoen
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1979

4.  Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.

Authors:  E A Fagan; R F Dyck; P N Maton; H J Hodgson; V S Chadwick; A Petrie; M B Pepys
Journal:  Eur J Clin Invest       Date:  1982-08       Impact factor: 4.686

5.  Effects of an elemental diet, inert bulk and different types of dietary fibre on the response of the intestinal epithelium to refeeding in the rat and relationship to plasma gastrin, enteroglucagon, and PYY concentrations.

Authors:  R A Goodlad; W Lenton; M A Ghatei; T E Adrian; S R Bloom; N A Wright
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

6.  Proctitis and colitis following diversion of the fecal stream.

Authors:  D J Glotzer; M E Glick; H Goldman
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

7.  Colostomy closure promotes cell proliferation and dimethylhydrazine-induced carcinogenesis in rat distal colon.

Authors:  O T Terpstra; E P Dahl; R C Williamson; J S Ross; R A Malt
Journal:  Gastroenterology       Date:  1981-09       Impact factor: 22.682

8.  Metronidazole in Crohn's disease. A double blind cross-over clinical trial.

Authors:  P Blichfeldt; J P Blomhoff; E Myhre; E Gjone
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

9.  Rate and pattern of epithelial cell proliferation in ulcerative colitis.

Authors:  E P Serafini; A P Kirk; T J Chambers
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

10.  The effects of diversion of intestinal contents on the progress of Crohn's disease of the large bowel.

Authors:  J H Burman; H Thompson; W T Cooke; J A Williams
Journal:  Gut       Date:  1971-01       Impact factor: 23.059

View more
  17 in total

Review 1.  The immunopathogenesis of Crohn's disease: a three-stage model.

Authors:  Gavin W Sewell; Daniel Jb Marks; Anthony W Segal
Journal:  Curr Opin Immunol       Date:  2009-08-08       Impact factor: 7.486

2.  Microparticles in Crohn's disease--has the dust settled?

Authors:  J J Powell; R S Harvey; R P Thompson
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

3.  The nucleotide synthesis enzyme CAD inhibits NOD2 antibacterial function in human intestinal epithelial cells.

Authors:  Amy L Richmond; Amrita Kabi; Craig R Homer; Noemí Marina-García; Kourtney P Nickerson; Alexey I Nesvizhskii; Arun Sreekumar; Arul M Chinnaiyan; Gabriel Nuñez; Christine McDonald
Journal:  Gastroenterology       Date:  2012-02-28       Impact factor: 22.682

4.  Mucosal enzyme activity for butyrate oxidation; no defect in patients with ulcerative colitis.

Authors:  E S Allan; S Winter; A M Light; A Allan
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

5.  Autoimmunity: increasing suspects in the CD4+ T cell lineup.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

Review 6.  Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases.

Authors:  Christopher D Packey; R Balfour Sartor
Journal:  Curr Opin Infect Dis       Date:  2009-06       Impact factor: 4.915

Review 7.  Innate immunity in inflammatory bowel disease: a disease hypothesis.

Authors:  D J B Marks; A W Segal
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

Review 8.  Advances in the pathogenesis and treatment of IBD.

Authors:  Nicholas A Braus; David E Elliott
Journal:  Clin Immunol       Date:  2009-03-24       Impact factor: 3.969

9.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Authors:  Daniel N Frank; Allison L St Amand; Robert A Feldman; Edgar C Boedeker; Noam Harpaz; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

Review 10.  Unravelling the complex genetics of inflammatory bowel disease.

Authors:  R K Russell; D C Wilson; J Satsangi
Journal:  Arch Dis Child       Date:  2004-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.